ADC Therapeutics stock price target lowered to $7 at H.C. Wainwright
NegativeFinancial Markets

H.C. Wainwright has lowered the stock price target for ADC Therapeutics to $7, reflecting concerns about the company's future performance. This adjustment is significant as it may impact investor confidence and the overall market perception of ADC Therapeutics, a company focused on developing targeted therapies for cancer. Investors will be closely watching how this change affects the stock's performance in the coming weeks.
— Curated by the World Pulse Now AI Editorial System